1. Home
  2. ASPN vs KROS Comparison

ASPN vs KROS Comparison

Compare ASPN & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • KROS
  • Stock Information
  • Founded
  • ASPN 2001
  • KROS 2015
  • Country
  • ASPN United States
  • KROS United States
  • Employees
  • ASPN N/A
  • KROS N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASPN Consumer Discretionary
  • KROS Health Care
  • Exchange
  • ASPN Nasdaq
  • KROS Nasdaq
  • Market Cap
  • ASPN 638.5M
  • KROS 565.0M
  • IPO Year
  • ASPN 2014
  • KROS 2020
  • Fundamental
  • Price
  • ASPN $6.36
  • KROS $15.55
  • Analyst Decision
  • ASPN Strong Buy
  • KROS Buy
  • Analyst Count
  • ASPN 8
  • KROS 14
  • Target Price
  • ASPN $19.29
  • KROS $20.56
  • AVG Volume (30 Days)
  • ASPN 2.1M
  • KROS 490.6K
  • Earning Date
  • ASPN 08-07-2025
  • KROS 08-06-2025
  • Dividend Yield
  • ASPN N/A
  • KROS N/A
  • EPS Growth
  • ASPN N/A
  • KROS N/A
  • EPS
  • ASPN N/A
  • KROS 0.47
  • Revenue
  • ASPN $397,175,000.00
  • KROS $232,844,000.00
  • Revenue This Year
  • ASPN N/A
  • KROS $5,579.44
  • Revenue Next Year
  • ASPN $8.56
  • KROS N/A
  • P/E Ratio
  • ASPN N/A
  • KROS $33.31
  • Revenue Growth
  • ASPN 11.18
  • KROS 85820.30
  • 52 Week Low
  • ASPN $4.16
  • KROS $9.12
  • 52 Week High
  • ASPN $30.24
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 37.21
  • KROS 59.85
  • Support Level
  • ASPN $6.42
  • KROS $14.98
  • Resistance Level
  • ASPN $7.23
  • KROS $16.07
  • Average True Range (ATR)
  • ASPN 0.28
  • KROS 0.65
  • MACD
  • ASPN -0.08
  • KROS 0.09
  • Stochastic Oscillator
  • ASPN 5.93
  • KROS 74.57

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: